{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:11Z","timestamp":1792788071452,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Keimyung University Dongsan Medical Center","award":["in 2025"],"award-info":[{"award-number":["in 2025"]}],"id":[{"id":"https:\/\/ror.org\/00tjv0s33","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04407-y","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:13:03Z","timestamp":1784725983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CFI-400945 enhances radiosensitivity in colorectal cancer models by promoting mitotic dysregulation and DNA damage-associated apoptosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jeong-Woo","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Young","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Min","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jun","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyowon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Uk","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"2","key":"4407_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344.","journal-title":"Gut"},{"issue":"1","key":"4407_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12935-022-02694-9","volume":"22","author":"E Salehitabar","year":"2022","unstructured":"Salehitabar E, Mahdevar M, Valipour Motlagh A, Forootan FS, Feizbakhshan S, Zohrabi D, Peymani M. Identification of genes with high heterogeneity of expression as a predictor of different prognosis and therapeutic responses in colorectal cancer: a challenge and a strategy. Cancer Cell Int. 2022;22(1):276.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4407_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13014-020-01695-0","volume":"15","author":"F Roeder","year":"2020","unstructured":"Roeder F, Meldolesi E, Gerum S, Valentini V, Rodel C. Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review. Radiat Oncol. 2020;15(1):262.","journal-title":"Radiat Oncol"},{"issue":"1","key":"4407_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","volume":"5","author":"YH Xie","year":"2020","unstructured":"Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5(1):22.","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"4407_CR5","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731\u201340.","journal-title":"N Engl J Med"},{"issue":"9666","key":"4407_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","volume":"373","author":"D Sebag-Montefiore","year":"2009","unstructured":"Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373(9666):811\u201320.","journal-title":"Lancet"},{"issue":"9","key":"4407_CR7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","volume":"36","author":"RD Hofheinz","year":"2025","unstructured":"Hofheinz RD, Fokas E, Benhaim L, Price TJ, Arnold D, Beets-Tan R, Guren MG, Hospers GAP, Lonardi S, Nagtegaal ID, et al. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36(9):1007\u201324.","journal-title":"Ann Oncol"},{"key":"4407_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.radonc.2019.05.001","volume":"138","author":"DLP Holyoake","year":"2019","unstructured":"Holyoake DLP, Partridge M, Hawkins MA. Systematic review and meta-analysis of small bowel dose-volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy. Radiother Oncol. 2019;138:38\u201344.","journal-title":"Radiother Oncol"},{"key":"4407_CR9","doi-asserted-by":"crossref","unstructured":"Deng S, Vlatkovic T, Li M, Zhan T, Veldwijk MR, Herskind C. Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer. Cancers (Basel) 2022, 14(19).","DOI":"10.3390\/cancers14194874"},{"issue":"1","key":"4407_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5(1):60.","journal-title":"Signal Transduct Target Ther"},{"key":"4407_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","volume":"108","author":"J Smith","year":"2010","unstructured":"Smith J, Tho LM, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res. 2010;108:73\u2013112.","journal-title":"Adv Cancer Res"},{"issue":"2","key":"4407_CR12","first-page":"244","volume":"4","author":"JA Nickoloff","year":"2021","unstructured":"Nickoloff JA, Taylor L, Sharma N, Kato TA. Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy. Cancer Drug Resist. 2021;4(2):244\u201363.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"4407_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13014-022-02171-7","volume":"17","author":"H Chen","year":"2022","unstructured":"Chen H, Han Z, Luo Q, Wang Y, Li Q, Zhou L, Zuo H. Radiotherapy modulates tumor cell fate decisions: a review. Radiat Oncol. 2022;17(1):196.","journal-title":"Radiat Oncol"},{"key":"4407_CR14","doi-asserted-by":"crossref","unstructured":"Pan B, Zheng B, Xing C, Liu J. Non-Canonical Programmed Cell Death in Colon Cancer. Cancers (Basel). 2022;14(14):3309.","DOI":"10.3390\/cancers14143309"},{"key":"4407_CR15","doi-asserted-by":"publisher","first-page":"5990","DOI":"10.1038\/ncomms6990","volume":"6","author":"SF Bakhoum","year":"2015","unstructured":"Bakhoum SF, Kabeche L, Wood MD, Laucius CD, Qu D, Laughney AM, Reynolds GE, Louie RJ, Phillips J, Chan DA, et al. Numerical chromosomal instability mediates susceptibility to radiation treatment. Nat Commun. 2015;6:5990.","journal-title":"Nat Commun"},{"issue":"2","key":"4407_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3892\/ol.2022.13389","volume":"24","author":"Z Duan","year":"2022","unstructured":"Duan Z, Cai L, Cao J, Wu W. Polo-like kinase 4 is associated with advanced TNM stages and reduced survival and its inhibition improves chemosensitivity in colorectal cancer. Oncol Lett. 2022;24(2):269.","journal-title":"Oncol Lett"},{"issue":"8","key":"4407_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41419-019-1778-8","volume":"10","author":"DH Kim","year":"2019","unstructured":"Kim DH, Ahn JS, Han HJ, Kim HM, Hwang J, Lee KH, Cha-Molstad H, Ryoo IJ, Jang JH, Ko SK, et al. Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability. Cell Death Dis. 2019;10(8):570.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4407_CR18","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s42003-025-09249-4","volume":"8","author":"J Fahrlander","year":"2025","unstructured":"Fahrlander J, Buhler M, Shih JM, Zordick C, Busse M, Becker M, Schonfelder G, Stolz A. A GPER-PKA-Centrin axis regulates centrosome numbers and centriole integrity in colon cancer cells. Commun Biol. 2025;8(1):1739.","journal-title":"Commun Biol"},{"issue":"19","key":"4407_CR19","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1038\/sj.emboj.7600393","volume":"23","author":"H Dodson","year":"2004","unstructured":"Dodson H, Bourke E, Jeffers LJ, Vagnarelli P, Sonoda E, Takeda S, Earnshaw WC, Merdes A, Morrison C. Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. EMBO J. 2004;23(19):3864\u201373.","journal-title":"EMBO J"},{"issue":"3","key":"4407_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3164\/jcbn.19-80","volume":"67","author":"M Fujimoto","year":"2020","unstructured":"Fujimoto M, Bo T, Yamamoto K, Yasui H, Yamamori T, Inanami O. Radiation-induced abnormal centrosome amplification and mitotic catastrophe in human cervical tumor HeLa cells and murine mammary tumor EMT6 cells. J Clin Biochem Nutr. 2020;67(3):240\u20137.","journal-title":"J Clin Biochem Nutr"},{"issue":"11","key":"4407_CR21","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ncb1320","volume":"7","author":"R Habedanck","year":"2005","unstructured":"Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA. The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol. 2005;7(11):1140\u20136.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"4407_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/ncb993","volume":"5","author":"C Wong","year":"2003","unstructured":"Wong C, Stearns T. Centrosome number is controlled by a centrosome-intrinsic block to reduplication. Nat Cell Biol. 2003;5(6):539\u201344.","journal-title":"Nat Cell Biol"},{"issue":"7252","key":"4407_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature08136","volume":"460","author":"NJ Ganem","year":"2009","unstructured":"Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460(7252):278\u201382.","journal-title":"Nature"},{"issue":"28","key":"4407_CR24","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.18632\/oncotarget.26853","volume":"10","author":"B He","year":"2019","unstructured":"He B, Gnawali N, Hinman AW, Mattingly AJ, Osimani A, Cimini D. Chromosomes missegregated into micronuclei contribute to chromosomal instability by missegregating at the next division. Oncotarget. 2019;10(28):2660\u201374.","journal-title":"Oncotarget"},{"issue":"16","key":"4407_CR25","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1038\/sj.onc.1207528","volume":"23","author":"M Castedo","year":"2004","unstructured":"Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene. 2004;23(16):2825\u201337.","journal-title":"Oncogene"},{"issue":"6","key":"4407_CR26","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.21873\/anticanres.12606","volume":"38","author":"MH Choe","year":"2018","unstructured":"Choe MH, Kim J, Ahn J, Hwang SG, Oh JS, Kim JS. Centrosome Clustering Is a Tumor-selective Target for the Improvement of Radiotherapy in Breast Cancer Cells. Anticancer Res. 2018;38(6):3393\u2013400.","journal-title":"Anticancer Res"},{"key":"4407_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.breast.2021.03.011","volume":"58","author":"A Parsyan","year":"2021","unstructured":"Parsyan A, Cruickshank J, Hodgson K, Wakeham D, Pellizzari S, Bhat V, Cescon DW. Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer. Breast. 2021;58:6\u20139.","journal-title":"Breast"},{"issue":"9","key":"4407_CR28","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1158\/1535-7163.MCT-24-0978","volume":"24","author":"IG Dominguez-Vigil","year":"2025","unstructured":"Dominguez-Vigil IG, Banik K, Baro M, Contessa JN, Hayman TJ. PLK4 Inhibition as a Strategy to Enhance Non-Small Cell Lung Cancer Radiosensitivity. Mol Cancer Ther. 2025;24(9):1350\u201361.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"4407_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1083\/jcb.200911102","volume":"188","author":"AJ Holland","year":"2010","unstructured":"Holland AJ, Lan W, Niessen S, Hoover H, Cleveland DW. Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability. J Cell Biol. 2010;188(2):191\u20138.","journal-title":"J Cell Biol"},{"issue":"2","key":"4407_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3892\/ijo.2018.4659","volume":"54","author":"Z Liao","year":"2019","unstructured":"Liao Z, Zhang H, Fan P, Huang Q, Dong K, Qi Y, Song J, Chen L, Liang H, Chen X, et al. High PLK4 expression promotes tumor progression and induces epithelial\u2013mesenchymal transition by regulating the Wnt\/beta\u2013catenin signaling pathway in colorectal cancer. Int J Oncol. 2019;54(2):479\u201390.","journal-title":"Int J Oncol"},{"key":"4407_CR31","doi-asserted-by":"publisher","first-page":"116115","DOI":"10.1016\/j.ejmech.2023.116115","volume":"265","author":"Q Lei","year":"2024","unstructured":"Lei Q, Yu Q, Yang N, Xiao Z, Song C, Zhang R, Yang S, Liu Z, Deng H. Therapeutic potential of targeting polo-like kinase 4. Eur J Med Chem. 2024;265:116115.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"4407_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4132\/jptm.2021.10.07","volume":"56","author":"H Oh","year":"2022","unstructured":"Oh H, Kim SG, Bae SU, Byun SJ, Kim S, Lee JH, Hwang I, Kwon SY, Lee HW. Polo-like kinase 4 as a potential predictive biomarker of chemoradioresistance in locally advanced rectal cancer. J Pathol Transl Med. 2022;56(1):40\u20137.","journal-title":"J Pathol Transl Med"},{"issue":"2","key":"4407_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ccr.2014.05.006","volume":"26","author":"JM Mason","year":"2014","unstructured":"Mason JM, Lin DC, Wei X, Che Y, Yao Y, Kiarash R, Cescon DW, Fletcher GC, Awrey DE, Bray MR, et al. Functional characterization of CFI-400945, a Polo-like kinase 4 inhibitor, as a potential anticancer agent. Cancer Cell. 2014;26(2):163\u201376.","journal-title":"Cancer Cell"},{"issue":"8","key":"4407_CR34","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1073\/pnas.1719760115","volume":"115","author":"M Kawakami","year":"2018","unstructured":"Kawakami M, Mustachio LM, Zheng L, Chen Y, Rodriguez-Canales J, Mino B, Kurie JM, Roszik J, Villalobos PA, Thu KL, et al. Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers. Proc Natl Acad Sci U S A. 2018;115(8):1913\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"4407_CR35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41416-019-0517-3","volume":"121","author":"ZW Veitch","year":"2019","unstructured":"Veitch ZW, Cescon DW, Denny T, Yonemoto LM, Fletcher G, Brokx R, Sampson P, Li SW, Pugh TJ, Bruce J, et al. Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial. Br J Cancer. 2019;121(4):318\u201324.","journal-title":"Br J Cancer"},{"issue":"1","key":"4407_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13014-024-02410-z","volume":"19","author":"S Pellizzari","year":"2024","unstructured":"Pellizzari S, Bhat V, Athwal H, Cescon DW, Allan AL, Parsyan A. PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer. Radiat Oncol. 2024;19(1):24.","journal-title":"Radiat Oncol"},{"issue":"46","key":"4407_CR37","doi-asserted-by":"publisher","first-page":"E10808","DOI":"10.1073\/pnas.1813310115","volume":"115","author":"K Oegema","year":"2018","unstructured":"Oegema K, Davis RL, Lara-Gonzalez P, Desai A, Shiau AK. CFI-400945 is not a selective cellular PLK4 inhibitor. Proc Natl Acad Sci U S A. 2018;115(46):E10808\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 13","key":"4407_CR38","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1242\/jcs.068502","volume":"123","author":"G Guderian","year":"2010","unstructured":"Guderian G, Westendorf J, Uldschmid A, Nigg EA. Plk4 trans-autophosphorylation regulates centriole number by controlling betaTrCP-mediated degradation. J Cell Sci. 2010;123(Pt 13):2163\u20139.","journal-title":"J Cell Sci"},{"issue":"22","key":"4407_CR39","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.cub.2013.09.037","volume":"23","author":"I Cunha-Ferreira","year":"2013","unstructured":"Cunha-Ferreira I, Bento I, Pimenta-Marques A, Jana SC, Lince-Faria M, Duarte P, Borrego-Pinto J, Gilberto S, Amado T, Brito D, et al. Regulation of autophosphorylation controls PLK4 self-destruction and centriole number. Curr Biol. 2013;23(22):2245\u201354.","journal-title":"Curr Biol"},{"issue":"22","key":"4407_CR40","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.cub.2013.09.019","volume":"23","author":"JE Klebba","year":"2013","unstructured":"Klebba JE, Buster DW, Nguyen AL, Swatkoski S, Gucek M, Rusan NM, Rogers GC. Polo-like kinase 4 autodestructs by generating its Slimb-binding phosphodegron. Curr Biol. 2013;23(22):2255\u201361.","journal-title":"Curr Biol"},{"issue":"5","key":"4407_CR41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.cell.2007.09.041","volume":"131","author":"MS Huen","year":"2007","unstructured":"Huen MS, Grant R, Manke I, Minn K, Yu X, Yaffe MB, Chen J. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell. 2007;131(5):901\u201314.","journal-title":"Cell"},{"key":"4407_CR42","doi-asserted-by":"crossref","unstructured":"Muntaqua D, Chhabra G, Anaya Aldrete KB, Ahmad N. Polo-like kinase 4: A molecular linchpin in cancer and its management. iScience 2025, 28(12):114186.","DOI":"10.1016\/j.isci.2025.114186"},{"issue":"9","key":"4407_CR43","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.7150\/jca.14307","volume":"7","author":"Z Li","year":"2016","unstructured":"Li Z, Dai K, Wang C, Song Y, Gu F, Liu F, Fu L. Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy. J Cancer. 2016;7(9):1125\u201332.","journal-title":"J Cancer"},{"issue":"4","key":"4407_CR44","first-page":"2159","volume":"41","author":"J Wang","year":"2019","unstructured":"Wang J, Zuo J, Wang M, Ma X, Gao K, Bai X, Wang N, Xie W, Liu H. Polo\u2013like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma. Oncol Rep. 2019;41(4):2159\u201367.","journal-title":"Oncol Rep"},{"issue":"5","key":"4407_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/sj.cdd.4401586","volume":"12","author":"J Milia","year":"2005","unstructured":"Milia J, Teyssier F, Dalenc F, Ader I, Delmas C, Pradines A, Lajoie-Mazenc I, Baron R, Bonnet J, Cohen-Jonathan E, et al. Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplication. Cell Death Differ. 2005;12(5):492\u2013501.","journal-title":"Cell Death Differ"},{"issue":"3","key":"4407_CR46","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4161\/cc.6.3.3834","volume":"6","author":"H Dodson","year":"2007","unstructured":"Dodson H, Wheatley SP, Morrison CG. Involvement of centrosome amplification in radiation-induced mitotic catastrophe. Cell Cycle. 2007;6(3):364\u201370.","journal-title":"Cell Cycle"},{"issue":"6239","key":"4407_CR47","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1126\/science.aaa5111","volume":"348","author":"YL Wong","year":"2015","unstructured":"Wong YL, Anzola JV, Davis RL, Yoon M, Motamedi A, Kroll A, Seo CP, Hsia JE, Kim SK, Mitchell JW, et al. Cell biology. Reversible centriole depletion with an inhibitor of Polo-like kinase 4. Science. 2015;348(6239):1155\u201360.","journal-title":"Science"},{"issue":"2","key":"4407_CR48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/ars.2013.5668","volume":"21","author":"WL Santivasi","year":"2014","unstructured":"Santivasi WL, Xia F. Ionizing radiation-induced DNA damage, response, and repair. Antioxid Redox Signal. 2014;21(2):251\u20139.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"4407_CR49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ijrobp.2013.01.011","volume":"86","author":"C Wang","year":"2013","unstructured":"Wang C, Lees-Miller SP. Detection and repair of ionizing radiation-induced DNA double strand breaks: new developments in nonhomologous end joining. Int J Radiat Oncol Biol Phys. 2013;86(3):440\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"4407_CR50","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.cell.2015.06.005","volume":"161","author":"EM Hatch","year":"2015","unstructured":"Hatch EM, Hetzer MW. Linking Micronuclei to Chromosome Fragmentation. Cell. 2015;161(7):1502\u20134.","journal-title":"Cell"},{"issue":"7383","key":"4407_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature10802","volume":"482","author":"K Crasta","year":"2012","unstructured":"Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, Nezi L, Protopopov A, Chowdhury D, Pellman D. DNA breaks and chromosome pulverization from errors in mitosis. Nature. 2012;482(7383):53\u20138.","journal-title":"Nature"},{"issue":"17","key":"4407_CR52","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1158\/1078-0432.CCR-23-3720","volume":"30","author":"HHY Lee","year":"2024","unstructured":"Lee HHY, Chow KL, Wong HS, Chong TY, Wong AST, Cheng GHW, Ko JMK, Siu HC, Yeung MCF, Huen MSY, et al. Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair-Deficient Uterine Leiomyosarcoma. Clin Cancer Res. 2024;30(17):3904\u201318.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4407_CR53","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41419-021-03919-x","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Yang J, Liu J, Cai Y, Han Y, Hu S, Ren S, Zhou X, Wang X. Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma. Cell Death Dis. 2021;12(7):640.","journal-title":"Cell Death Dis"},{"issue":"17","key":"4407_CR54","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1093\/nar\/gkn550","volume":"36","author":"A Kinner","year":"2008","unstructured":"Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008;36(17):5678\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4407_CR55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s13148-011-0044-4","volume":"2","author":"DV Firsanov","year":"2011","unstructured":"Firsanov DV, Solovjeva LV, Svetlova MP. H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues. Clin Epigenetics. 2011;2(2):283\u201397.","journal-title":"Clin Epigenetics"},{"issue":"13","key":"4407_CR56","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.1074\/jbc.275.13.9390","volume":"275","author":"EP Rogakou","year":"2000","unstructured":"Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem. 2000;275(13):9390\u20135.","journal-title":"J Biol Chem"},{"key":"4407_CR57","doi-asserted-by":"crossref","unstructured":"Trakarnphornsombat W, Kimura H. Live-cell tracking of gamma-H2AX kinetics reveals the distinct modes of ATM and DNA-PK in the immediate response to DNA damage. J Cell Sci. 2023;136(8):jcs260698 .","DOI":"10.1242\/jcs.260698"},{"key":"4407_CR58","doi-asserted-by":"crossref","unstructured":"Averbeck D, Rodriguez-Lafrasse C. Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts. Int J Mol Sci. 2021;22(20):11047.","DOI":"10.3390\/ijms222011047"},{"issue":"5","key":"4407_CR59","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/HP.0000000000001601","volume":"123","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Cao F, Liu H. Radiation-induced Cell Death and Its Mechanisms. Health Phys. 2022;123(5):376\u201386.","journal-title":"Health Phys"},{"issue":"11","key":"4407_CR60","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1007\/s00432-020-03346-z","volume":"146","author":"SL Kerschner-Morales","year":"2020","unstructured":"Kerschner-Morales SL, Kuhne M, Becker S, Beck JF, Sonnemann J. Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing\u2019s sarcoma cells. J Cancer Res Clin Oncol. 2020;146(11):2871\u201383.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4407_CR61","doi-asserted-by":"publisher","first-page":"898474","DOI":"10.3389\/fgene.2022.898474","volume":"13","author":"XR Mu","year":"2022","unstructured":"Mu XR, Ma MM, Lu ZY, Liu J, Xue YT, Cao J, Zeng LY, Li F, Xu KL, Wu QY. Effects of the PLK4 inhibitor Centrinone on the biological behaviors of acute myeloid leukemia cell lines. Front Genet. 2022;13:898474.","journal-title":"Front Genet"},{"issue":"12","key":"4407_CR62","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nchembio1207-739","volume":"3","author":"WA Weiss","year":"2007","unstructured":"Weiss WA, Taylor SS, Shokat KM. Recognizing and exploiting differences between RNAi and small-molecule inhibitors. Nat Chem Biol. 2007;3(12):739\u201344.","journal-title":"Nat Chem Biol"},{"issue":"6","key":"4407_CR63","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nbt831","volume":"21","author":"AL Jackson","year":"2003","unstructured":"Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol. 2003;21(6):635\u20137.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"4407_CR64","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, Liu IH, Chiou SH, Salahudeen AA, Smith AR, et al. Organoid Modeling of the Tumor Immune Microenvironment. Cell. 2018;175(7):1972\u201388. e1916.","journal-title":"Cell"},{"issue":"9","key":"4407_CR65","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1073\/pnas.0830918100","volume":"100","author":"K Rothkamm","year":"2003","unstructured":"Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A. 2003;100(9):5057\u201362.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04407-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:02:28Z","timestamp":1792432948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04407-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4407"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04407-y","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Institutional Review Board of Keimyung University Dongsan Medical Center (IRB No. 2016-08-020). Written informed consent was obtained from all participants or their legally authorized representatives.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"342"}}